LEMAITRE VASCULAR INC

LeMaitre Vascular, Inc. is a medical device company that develops, manufactures, and markets vascular devices and provides human tissue cryopreservation services. Its products are primarily designed for use in open surgical procedures, including open vascular and open cardiac surgeries, to treat peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company's portfolio features six product categories encompassing twenty-four distinct product types, such as valvulotomes, balloon catheters, carotid shunts, vascular grafts, patches, and vessel closure systems. LeMaitre Vascular primarily serves vascular surgeons, while also providing products and tissue processing services to cardiac surgeons, general surgeons, and neurosurgeons.

The company operates globally, conducting direct-to-hospital sales and marketing through regional headquarters and offices across North America, Europe, and Asia Pacific. Its corporate headquarters is located in Burlington, Massachusetts, where it also maintains primary manufacturing operations. Additional corporate and sales presences include a European headquarters in Sulzbach, Germany, an Asia Pacific headquarters in Singapore, and multiple regional sales offices in countries such as Canada, Italy, Spain, England, Ireland, France, Switzerland, Japan, China, Australia, Korea, and Thailand. Outside these direct territories, the company distributes products via independent distributors.

Summary of the business section of Lemaitre Vascular's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

“We had 655 employees, including 646 full-time employees, as of December 31, 2025.”